Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Transactions in connection with share buy-back program
-
Justin Sun: Forbes Cover Marks New Beginning, Vows 40-Year Commitment to Crypto Industry
-
Costamare Inc. Announces Costamare Bulkers Holdings Limited Virtual Analyst And Investor Day April 9
-
Costamare Inc. Announces Costamare Bulkers Holdings Limited Virtual Analyst And Investor Day April 9
-
WANG AND LEE GROUP, INC. ANNOUNCES STRATEGIC INVESTMENT IN TROOPS, INC. TO DRIVE INNOVATION IN SMART BUILDING SOLUTIONS AND EXPAND ESG TOKEN REWARD ECOSYSTEM
-
Vishay Intertechnology Announces 2025 Annual Meeting of Stockholders
-
Greenheart Gold Announces Trading on the OTCQB Venture Market in the United States
-
Oncotelic Therapeutics Publishes New Research Demonstrating Positive Prognostic Impact of Methylated TGFB2 and MGMT in Adult Glioblastoma Patients, Introduces Interactive PDAOAI
-
CERo Therapeutics Holdings, Inc. Receives FDA Clearance of Second Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Lead Compound CER-1236 in Solid Tumors
-
Voltus Registers First Resource Under NYISO’s Distributed Energy Resource Participation Model
-
Xeriant Announces Successful Fire Test of NEXBOARD™
-
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
-
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas
-
Atsign Advances Private Website Security with the Power of Invisibility
-
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
-
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
-
TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1
-
Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update
-
CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
-
Shirofune Wins Gold in the 2025 ANA Marketing Technology Awards
-
CorVista Health Presents New Data on Non-Invasive Point of Care Testing for Pulmonary Capillary Wedge Pressure (PCWP) Elevation Using Machine Learning
-
FluidForm Bio™ Announces Participation in Venture Summit West
-
IN8bio to Present New Preclinical Data on Novel Gamma-Delta (γδ) T cell Engager Platform for Cancer Immunotherapy at AACR Annual Meeting 2025
-
Biocardia Phase 3 CardiAMP-HF Trial of Novel Cardiac Cell Therapy for Ischemic Heart Failure Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two Years
-
Community “Angels" Help Kids, Families, Seniors, Veterans and the Unhoused to Receive Free Vision Care and More
-
Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
Werewolf Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
-
Norden Crown Announces Name Change to Domestic Metals Corp.
-
Theriva™ Biologics Announces Positive Outcomes from the Second Meeting of the Independent Data Monitoring Committee for VIRAGE, the Company’s Phase 2b Clinical Trial of VCN-01 in Combination with
-
Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site
-
ProStar and Emlid Partner to Deliver Centimeter Accuracy for Critical Infrastructure Mapping Worldwide
-
electroCore Extends VA Contract for Five Years
-
LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
NewAmsterdam Pharma to Present at the 24th Annual Needham Virtual Healthcare Conference
-
ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024
-
Rapid7 Recognizes Top Global Partners With 2025 Partner Of The Year Awards
-
Synergy CHC Reports its Eighth Consecutive Quarter of Profitability and its Fourth Quarter and Full Year 2024 Financial Results
-
Nanox Announces Fourth Quarter of 2024 Financial Results and Provides Business Updates
-
OKYO Pharma Announces Positive Data in Long-Term Stability of Urcosimod
-
Australian Oilseeds Announces Second Quarter Fiscal 2025 Financial Results
-
Luckin Coffee Files 2024 Annual Report on Form 20-F
-
Biora Therapeutics Successfully Completes Restructuring Process
-
360 Privacy Announces Strategic Executive Appointments Following $36 Million Growth Investment
-
Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist
-
Nasdaq Champions Smart Regulatory Reform to Strengthen the World’s Leading Capital Markets and Drive American Economic Growth
-
Clip Money Inc. Reports 2024 Year End Results
-
Emergent BioSolutions Announces Stock Repurchase Program
-
Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
-
Community “Angels" Help Kids, Families, Seniors, Veterans and the Unhoused to Receive Free Vision Care and More
-
Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
